Cargando…
Decreased interleukin-35 levels and CD4(+)EBI3(+) T cells in patients with type 1 diabetes and the effects of the antibody against CD20 (rituximab)
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Termedia Publishing House
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811298/ https://www.ncbi.nlm.nih.gov/pubmed/33488880 http://dx.doi.org/10.5114/aoms.2020.101510 |